420 research outputs found

    The Catholic Moral Tradition on Providing Food and Fluids

    Get PDF

    Pain Acceptance and Anxiety in Adolescents with Sickle Cell Disease

    Get PDF
    Sickle cell disease (SCD), an inherited blood disorder, causes a patient’s red blood cells to form into a sickle shape and clot in the vessels. Individuals with SCD can suffer from severe pain due to the restricted flow of blood. Pain acceptance is a crucial component of a patient's quality of life. The ability to accept the pain that comes with SCD can enable patients to have more productive and fulfilling lives. Anxiety in adolescents with SCD can have a significant impact on their functionality and overall development. The many factors contributing to anxiety in adolescents can worsen when combined with the stress of having a chronic illness. The aim of the current study was to explore the relationship between pain acceptance and anxiety in a sample of adolescents with SCD. Data for the following study was collected at a children’s hospital in the Midwest. Participants included 30 adolescents, aged 12-18 years (M=14.5). The data set included male (46.7%) and female (53.3%) participants. Participants identified as either African American (85.2%) or biracial (14.8%). The Chronic Pain Acceptance Questionnaire (CPAQ) a 20-item self-report measure, was used to gather data on pain acceptance in children. The Spence Children’s Anxiety Scale 44-item self-report measure was used to assess anxiety in children. Higher scores represent better ability to accept pain and higher levels of anxiety, respectively. A bivariate correlation between adolescent self-report scores on the CPAQ and SCAS showed no significant association between pain acceptance and anxiety in adolescents with SCD, r=.10, p>0.05. There is insufficient evidence to conclude a significant linear relationship between self-report scores on the SCAS and the CPAQ is present among adolescents with SCD. Limitations to this study included a narrow sample size. The influence of an unidentified third variable such as the development of strong coping skills or having already come to terms with the reality of their diagnosis could be present. Unknown contributing factors to participants’ anxiety could have potentially impacted results. Including, pain levels on the day of the survey and their mindset when taking the survey. Further research regarding contributors to high levels of anxiety in patients with SCD is needed to determine if additional factors influencing anxiety are present in their daily life. Potential examples include participants support systems or the type/severity of their SCD diagnosis

    Identification and characterisation of resistance to the take-all fungus in wheat

    Get PDF
    Take-all disease, caused by the soil-borne fungus Gaeumannomyces graminis var. tritici, is the most devastating root disease of wheat around the world. Typical take-all symptoms show as black necrotic lesions on the roots and when severe can cause premature ripening and stunting of the wheat crop, resulting in poor grain quality and yield loss. Both cultural and chemical control methods are moderately successful at controlling take-all but plant material that would be useful for take-all control via a genetic approach has not been identified in the UK or elsewhere. The main aim of this project was to identify resistance to take-all within wheat (Triticum spp.). This study explored a new phenomenon in hexaploid wheat (Triticum aestivum) which restricts take-all inoculum build-up (TAB) in the soil during a first wheat crop and also explored tissue based resistance to take-all in hexaploid wheat and a related diploid wheat species, Triticum monococcum. Forty-nine elite wheat varieties were evaluated for their ability to build-up take-all inoculum in first wheat field trials using a soil core bioassay method, and pedigree and molecular marker analyses were carried out to investigate the genetic sources of the TAB trait. The effect of a low or high TAB first wheat variety on take-all disease and yield in a following second wheat crop was evaluated in crop rotation field trials. This work demonstrated that there are significant differences between current elite wheat varieties screened for the TAB trait and that there are probably multiple genetic sources of the trait. Take-all disease was lower and yields generally higher in a second wheat crop after a low TAB first wheat. The susceptibility of fifty elite hexaploid wheat varieties and thirty-four T. monococcum accessions to take-all was evaluated in third wheat field trials. Both T. aestivum (variety Hereford) and T. monococcum (MDR031 and MDR046) genotypes with some partial resistance to take-all were identified. A seedling pot test method as a screen for resistance was also explored but the results were found not to be closely related to the susceptibility of adult plants in field trials. The implications of these new findings for the control of take-all and further research are discussed.This project was funded by a CASE PhD studentship from the Biotechnology and Biological Sciences Research Council (BBSRC), with industrial support from HGCA

    Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer

    Get PDF
    The RUNX1 transcription factor is widely recognised for its tumour suppressor effects in leukaemia. Recently a putative link to breast cancer has started to emerge, however the function of RUNX1 in breast cancer is still unknown. To investigate if RUNX1 expression was important to clinical outcome in primary breast tumours a tissue microarray (TMA) containing biopsies from 483 patients with primary operable invasive ductal breast cancer was stained by immunohistochemistry. RUNX1 was associated with progesterone receptor (PR)-positive tumours (P<0.05), more tumour CD4+(P<0.05) and CD8+(P<0.01) T-lymphocytic infiltrate, increased tumour CD138+plasma cell (P<0.01) and more CD68+macrophage infiltrate (P<0.001). RUNX1 expression did not influence outcome of oestrogen receptor (ER)-positive or HER2-positive disease, however on univariate analysis a high RUNX1 protein was significantly associated with poorer cancer-specific survival in patients with ER-negative (P<0.05) and with triple negative (TN) invasive breast cancer (P<0.05). Furthermore, multivariate Cox regression analysis of cancer-specific survival showed a trend towards significance in ER-negative patients (P<0.1) and was significant in triple negative patients (P<0.05). Of relevance, triple negative breast cancer currently lacks good biomarkers and patients with this subtype do not benefit from the option of targeted therapy unlike patients with ER-positive or HER2-positive disease. Using multivariate analysis RUNX1 was identified as an independent prognostic marker in the triple negative subgroup. Overall, our study identifies RUNX1 as a new prognostic indicator correlating with poor prognosis specifically in the triple negative subtype of human breast cancer
    • …
    corecore